Literature DB >> 13405753

Megaloblastic anemia during primidone (mysoline) therapy.

W N CHRISTENSON, J E ULTMANN, D M ROSEMAN.   

Abstract

Entities:  

Keywords:  ANEMIA, HYPERCHROMIC/etiology and pathogenesis; ANTICONVULSANTS/injurious effects

Mesh：

Substances：

Year:  1957        PMID： 13405753     DOI： 10.1001/jama.1957.82970460003008a

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  8 in total

1.  Lesions in folic acid metabolism induced by primidone.

Authors:  H BAKER; O FRANK; S H HUTNER; S AARONSON; H ZIFFER; H SOBOTKA
Journal:  Experientia       Date:  1962-05-15

2.  Megaloblastic anaemia associated with phenobarbital therapy.

Authors:  A L SHERWIN; R H WAIT; B A COOPER
Journal:  Can Med Assoc J       Date:  1960-02-13       Impact factor: 8.262

3.  Megaloblastic anaemia due to anticonvulsant therapy: report of a case responding to vitamin B12.

Authors:  P C MACINTOSH; J L HUTCHISON
Journal:  Can Med Assoc J       Date:  1960-02-13       Impact factor: 8.262

4.  Megaloblastic anaemia and vitamin-B12 deficiency after anticonvulsant therapy; report of two cases.

Authors:  P KIDD; D L MOLLIN
Journal:  Br Med J       Date:  1957-10-26

5.  Folic-acid studies in megaloblastic anaemia due to primidone.

Authors:  I CHANARIN; P C ELMES; D L MOLLIN
Journal:  Br Med J       Date:  1958-07-12

6.  Serum folic-acid and vitamin-B12 levels in anticonvulsant therapy.

Authors:  J S Malpas; G H Spray; L J Witts
Journal:  Br Med J       Date:  1966-04-16

7.  Nitrofurantoin and peripheral neuropathy with megaloblastic anaemia.

Authors:  J S Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-06       Impact factor: 10.154

8.  Reversible absorptive defects in anticonvulsant megaloblastic anaemia.

Authors:  E H Reynolds; J F Hallpike; B M Phillips; D M Matthews
Journal:  J Clin Pathol       Date:  1965-09       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.